Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
NCT02579096Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of allopurinol, febuxostat in gout, sponsored by VA Office of Research & Development. Started Mar 2017; status: completed.
02
Drugs
allopurinolfebuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT02579096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579096.